Cite Filings / UTHR / 0000102909-26-002553
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

UNITED THERAPEUTICS Corp · Filed 2026-03-27 · Acc 0000102909-26-002553

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-03-27 4 CFO AND TREASURER sold 10,000 shares at an average $535.90 ($5,359,005)
  • 2026-03-27 4 Chairperson & CEO sold 9,500 shares at an average $535.81 ($5,090,216)
  • 2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-03-26 144 Sale of Securities
  • 2026-03-26 4 Director sold 2,000 shares at an average $539.17 ($1,078,332)
  • 2025-05-12 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…